Earnings4552JCR Pharmaceuticals Co.,Ltd.
JCR Pharmaceuticals Reports Q1 Revenue of 9.7 billion, Up 13%
TOKYO, Jul 30 (Pulse News Wire) – Jcr Pharmaceuticals Co., Ltd. (4552.T) reported consolidated results for Q1 FY2027 (ending March 2027).
Revenue was ¥9.7 billion (+13.2% YoY). operating profit was -¥2,103 million. net profit was -¥1,907 million.
Total assets stood at ¥110 billion with an equity ratio of 40.6%. The company declared an annual dividend of ¥10 per share. The full-year forecast for the current fiscal year is revenue of ¥45.7 billion (+13.3%).
Financial results — FY2027/3 (consolidated)
| Metric | Current | YoY |
|---|---|---|
| Revenue | ¥9,700M | +13.2% |
| Operating profit | ¥-2,103M | n/a |
| Net profit | ¥-1,907M | n/a |
Next period forecast
Revenue
¥45,700M
+13.3%Op. profit
¥1,100M
+98.2%Net profit
¥200M
-90.8%Source: TDNet filing · Figures in millions of yen
End of article